# US 2017/0281672 A1 · Systems and methods for delivery of peptides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0281672 A1
- Document ID: US20170281672A1
- Status: Published application
- Kind: A1
- Application number: 15/487,818
- Filed: 2017-04-14
- Published: 2017-10-05
- Earliest claimed: 2013-03-13
- Assignees: Transdermal Biotechnology, Inc.
- Applicants: Transdermal Biotechnology, Inc.
- Inventors: Nicholas V. Perricone
- Web page: https://patentgrep.com/patent/US20170281672A1

## CPC

- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61K 38/06: Tripeptides
- A61K 38/066: {TRH, thyroliberin, thyrotropin releasing hormone}
- A61K 38/095: Oxytocins; Vasopressins; Related peptides
- A61K 38/2271: {Neuropeptide Y}
- A61K 38/28: Insulins
- A61K 38/34: Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
- A61K 47/544: {Phospholipids}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention generally relates to compositions and methods for topical or transdermal delivery. The compositions can be used in a variety of applications. In some cases, the composition may include nitric oxide and/or peptides. The nitric oxide and/or peptide may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present in liposomes, micelles, or other vesicles containing nitric oxide, peptides, or both. The composition can take the form of a gel, a cream, a lotion, an ointment, a solution, a solid “stick,” etc., that can be rubbed or sprayed onto the skin. The composition can also be applied to a mucosal surface in some instances. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.

## Claims

### Claim at position 1

1-63. (canceled)

### Claim 64

A composition, comprising:
a carrier comprising thyrotropin-releasing hormone (TRH) and lecithin entrapping molecular nitric oxide, wherein the composition is stable at room temperature.

### Claim 65 (depends on 64)

The composition of claim 64, wherein the carrier further comprises polyenylphosphatidylcholine.

### Claim 66 (depends on 64)

The composition of claim 64, wherein the composition comprises a liquid crystal structure.

### Claim 67 (depends on 64)

The composition of claim 64, wherein the composition comprises no more than about 250 ppm of water by weight of the composition.

### Claim 68 (depends on 64)

The composition of claim 64, wherein the lecithin is present at at least about 0.25% by weight of the composition.

### Claim 69 (depends on 64)

The composition of claim 64, wherein the molecular nitric oxide is present at at least about 0.5% by weight of the composition without nitric oxide.

### Claim 70 (depends on 64)

The composition of claim 64, wherein the molecular nitric oxide is present within the composition as a gas.

### Claim 71 (depends on 64)

The composition of claim 64, wherein the molecular nitric oxide is bound by hydrogen bonds or van der Waals forces to the lecithin.

### Claim 72 (depends on 64)

The composition of claim 64, wherein the composition is a cream.

### Claim 73 (depends on 64)

The composition of claim 64, wherein the composition is a gel.

### Claim 74

A composition, comprising:
a carrier comprising thyrotropin-releasing hormone (TRH) and lecithin entrapping molecular nitric oxide, wherein the first phase comprises no more than about 250 ppm of water by weight of the composition

### Claim 75 (depends on 74)

The composition of claim 74, wherein the carrier further comprises polyenylphosphatidylcholine.

### Claim 76 (depends on 74)

The composition of claim 74, wherein the composition comprises a liquid crystal structure.

### Claim 77 (depends on 74)

The composition of claim 74, wherein the composition is stable at room temperature.

### Claim 78 (depends on 74)

The composition of claim 74, wherein the lecithin is present at at least about 0.25% by weight of the composition.

### Claim 79 (depends on 74)

The composition of claim 74, wherein the molecular nitric oxide is present at at least about 0.5% by weight of the composition without nitric oxide.

### Claim 80 (depends on 74)

The composition of claim 74, wherein the molecular nitric oxide is present within the composition as a gas.

### Claim 81 (depends on 74)

The composition of claim 74, wherein the molecular nitric oxide is bound by hydrogen bonds or van der Waals forces to the lecithin.

### Claim 82 (depends on 74)

The composition of claim 74, wherein the composition is a cream.

### Claim 83 (depends on 74)

The composition of claim 74, wherein the composition is a gel.
